Nasdaq Slips 0.4% on Broadcom Warning, Dow Rises with Healthcare
1h ago|4 min readStandard
Fazen Markets Editorial Desk
Collective editorial team · methodology
nasdaqdow-jones
Fazen Markets Editorial Desk
Collective editorial team · methodology
Trades XAUUSD 24/5 on autopilot. Verified Myfxbook performance. Free forever.
Risk warning: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. The majority of retail investor accounts lose money when trading CFDs. Vortex HFT is informational software — not investment advice. Past performance does not guarantee future results.
The Nasdaq Composite declined 0.4% to 16,950 points on June 4, 2026, pressured by a significant downturn in chipmaker Broadcom following a lowered sales forecast. Conversely, the Dow Jones Industrial Average gained 0.3% to 39,200 points, buoyed by strength in its healthcare and financial components, including UnitedHealth Group and JPMorgan Chase. The S&P 500 ended the session nearly flat, down just 0.05%, as the divergent performance underscored a sector rotation driven by company-specific news and macroeconomic uncertainty. The moves were reported by investing.com.
This sector-specific divergence arrives during a period of heightened sensitivity to corporate guidance. The current macroeconomic backdrop features the Federal Funds Target Rate holding steady at a range of 5.25%-5.50%, placing a premium on earnings visibility. Broadcom's warning acts as a catalyst, triggering a reappraisal of high-valuation technology stocks whose growth projections may be vulnerable to slowing enterprise spending. The sector rotation reflects a flight to perceived safety and stable cash flows amid concerns over the sustainability of the tech rally.
The last comparable event occurred on April 25, 2026, when Meta Platforms issued softer-than-expected revenue guidance, leading to a 2.1% single-day drop in the Nasdaq. The current pullback is more concentrated, however, focusing on semiconductor and hardware-exposed names rather than the broader tech sector. What changed is the market's reception to forward-looking statements, punishing any sign of weakness more severely than in previous quarters. Investors are scrutinizing Q2 earnings pre-announcements for confirmation of economic resilience.
Broadcom's stock fell 8.5% to $1,420 per share after the company revised its full-year sales forecast downward by approximately 5%. This decline erased roughly $85 billion from the company's market capitalization. The Philadelphia Semiconductor Index (SOX) fell in sympathy, dropping 2.1% on the session. In contrast, the Dow Jones U.S. Healthcare Sector Index rose 0.8%, outperforming the broader market.
The divergence is further illustrated by the performance of key index components. UnitedHealth Group advanced 1.8%, contributing nearly 50 points to the Dow's price-weighted gain. JPMorgan Chase added 1.2%. The Invesco QQQ Trust, which tracks the Nasdaq-100, saw a volume of 45 million shares, 15% above its 30-day average, indicating elevated trading activity around tech names. The VIX volatility index closed at 14.5, a modest increase from the previous day's 13.8.
| Metric | Nasdaq Composite | Dow Jones Industrial Average |
|---|---|---|
| Price Change | -0.4% | +0.3% |
| Closing Level | 16,950 | 39,200 |
| YTD Performance | +9.5% | +4.2% |
Broadcom's warning signals potential weakness in enterprise demand for networking and custom chip solutions, directly impacting peers like Marvell Technology and Arista Networks, which fell 4.5% and 3.2%, respectively. The sell-off in semiconductors created a second-order buying opportunity in companies with more defensive revenue streams, such as pharmaceutical giant Merck, which rose 1.5%. Financials benefited from steady loan growth expectations and stable net interest margins as rate cut expectations are pushed further into the future.
A key counter-argument is that Broadcom's issues may be company-specific, related to its integration of recent acquisitions rather than a broad-based tech slowdown. The strong performance of software-as-a-service companies, with the iShares Expanded Tech-Software Sector ETF (IGV) ending the day up 0.2%, supports this view. Positioning data from major prime brokers indicates institutional investors have been reducing exposure to semiconductor equipment makers over the past week, with flows rotating into consumer staples and utilities ETFs.
The immediate catalyst is the U.S. monthly jobs report scheduled for release on June 6, 2026. A strong report could reinforce the higher-for-longer rates narrative, further pressuring growth-sensitive tech stocks. Conversely, a weak report might revive rate cut hopes but could also spark broader economic concerns. The next significant test for the tech sector will be the Q2 earnings season, which begins in earnest with major bank reports on July 14, 2026.
Technical levels to monitor include the Nasdaq's 50-day moving average at 16,850, which represents near-term support. A breach below this level could trigger further selling toward 16,500. For the Dow, resistance sits at the 39,500 level, a peak it has tested unsuccessfully twice in the past month. The 10-year Treasury yield, currently at 4.35%, remains a key barometer; a move above 4.50% would likely intensify the rotation out of growth equities.
Broadcom stock fell 8.5% after the company lowered its full-year sales forecast, citing weaker-than-expected demand from its large enterprise clients. This guidance cut spooked investors who had priced in strong growth for the semiconductor and infrastructure software leader. The decline had a pronounced effect on the Nasdaq due to Broadcom's significant market capitalization and its status as a bellwether for technology hardware spending.
Historically, the Dow Jones Industrial Average, composed of 30 large, established companies, tends to outperform the tech-heavy Nasdaq during periods of economic uncertainty or rising interest rates. For example, during the rate hike cycle of the first half of 2023, the Dow declined 2.5% while the Nasdaq fell over 8%. The Dow's defensive orientation and exposure to cyclical sectors like healthcare and finance often provide relative stability compared to the growth-focused Nasdaq.
Sector rotation significantly impacts index funds that track specific markets. A rotation into healthcare and financials benefits a fund like the SPDR Dow Jones Industrial Average ETF (DIA), while a sell-off in technology hurts the Invesco QQQ Trust (QQQ). For broad market funds like the SPDR S&P 500 ETF (SPY), the net effect depends on the magnitude of the moves in different sectors, often resulting in muted overall performance during rotational periods, as witnessed in this session.
A single earnings warning from a tech giant fractured the market, punishing speculative growth while rewarding defensive value.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. CFD trading carries high risk of capital loss.
Vortex HFT is our free MT4/MT5 Expert Advisor. Verified Myfxbook performance. No subscription. No fees. Trades 24/5.
Trade 800+ global stocks & ETFs
Start TradingSponsored
Open a demo account in 30 seconds. No deposit required.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.